Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using 111In-trastuzumab (Herceptin) Fab fragments

Y Tang, J Wang, DA Scollard, H Mondal… - Nuclear medicine and …, 2005 - Elsevier
Trastuzumab (Herceptin) Fab were prepared by digestion of intact IgG with immobilized papain,
derivatized with diethylenetriaminepentaacetic acid (DTPA) and radiolabeled with 111 In…

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human …

K McLarty, B Cornelissen, DA Scollard, SJ Done… - European journal of …, 2009 - Springer
Purpose The purpose of the study was to investigate the associations between uptake of 111
In-DTPA-trastuzumab, tumour HER2 density and response to trastuzumab (Herceptin) of …

Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo

…, H Fonge, Z Cai, D Scollard… - Molecular …, 2012 - ACS Publications
In this study, we have looked at enhancing tumor uptake and intracellular delivery of gold
nanoparticles (AuNPs) while reducing the systemic exposure by systematic evaluation of the …

Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA …

…, B Cornelissen, Z Cai, DA Scollard… - Journal of Nuclear …, 2009 - Soc Nuclear Med
… McLarty K, Cornelissen B, Scollard D, Done S, Chun K, Reilly R. Associations between
the uptake of 111 In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) …

[HTML][HTML] Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of 111In-DTPA-human epidermal growth factor in patients with …

KA Vallis, RM Reilly, D Scollard, P Merante… - American journal of …, 2014 - ncbi.nlm.nih.gov
The safety, pharmacokinetics, biodistribution and radiation dosimetry of 111 In-DTPA-hEGF,
an Auger electron-emitting radiopharmaceutical, were evaluated in a first-in-human trial. …

[HTML][HTML] Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide

JA McCart, N Mehta, D Scollard, RM Reilly… - Molecular Therapy, 2004 - cell.com
Oncolytic vaccinia viruses (VV) have demonstrated tumor specificity, high levels of
transgene expression, and anti-tumor effects. The ability to visualize vector biodistribution …

In vitro and in vivo evaluation of WK‐X‐34, a novel inhibitor of P‐glycoprotein and BCRP, using radio imaging techniques

V Jekerle, W Klinkhammer, DA Scollard… - … journal of cancer, 2006 - Wiley Online Library
Overexpression of the multidrug resistance proteins P‐glycoprotein (Pgp) and breast cancer
resistance protein (BCRP) results in treatment failure of many malignancies including …

Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron–emitting …

RM Reilly, P Chen, J Wang, D Scollard… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Our objective was to evaluate the pharmacokinetics, normal tissue distribution, radiation
dosimetry, and toxicology of human epidermal growth factor (hEGF) labeled with 111 In ( 111 In-…

Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF

Z Cai, Z Chen, KE Bailey, DA Scollard… - Journal of Nuclear …, 2008 - Soc Nuclear Med
The Auger electron–emitting radiopharmaceutical 111 In-diethylenetriaminepentaacetic
acid human epidermal growth factor ( 111 In-DTPA-hEGF) binds the epidermal growth factor …

Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [99mTc]-HYNIC-trastuzumab (Herceptin) Fab fragments

Y Tang, D Scollard, P Chen, J Wang… - Nuclear medicine …, 2005 - journals.lww.com
Objective To evaluate the ability of trastuzumab (Herceptin) Fab, labelled with 99m Tc
through introduced hydrazinenicotinamide (HYNIC) functionalities, to image HER2/neu-…